Stocks and Investing Stocks and Investing
Fri, December 23, 2022
Thu, December 22, 2022
Wed, December 21, 2022
Tue, December 20, 2022
Mon, December 19, 2022

Serge Belanger Initiated (VRDN) at Strong Buy and Held Target at $45 on, Dec 19th, 2022


Published on 2024-10-28 00:38:46 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Initiated "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $45 on, Dec 19th, 2022.

Serge has made no other calls on VRDN in the last 4 months.



There are 3 other peers that have a rating on VRDN. Out of the 3 peers that are also analyzing VRDN, 0 agree with Serge's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Serge


  • Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $51 on, Friday, December 16th, 2022
  • Douglas Tsao of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $35 on, Thursday, December 1st, 2022
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $46 on, Tuesday, November 15th, 2022